Merck & Co. Inc., Eli Lilly and Co., and Amgen Inc., along with the Association of National Advertisers Inc., filed suit against the U.S. Department of Health and Human Services (HHS) to stop a rule requiring TV ads for most prescription drugs to include the wholesale acquisition cost (WAC) of the drug.